Leeward Financial Partners, LLC Amgen Inc Transaction History

Leeward Financial Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $1.86 Million - $2.2 Million	-8,691 Reduced 86.9%	1,310 $290,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $141,344 - $172,275	626 Added 6.68%	10,001 $2.42 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $60,921 - $77,408	-266 Reduced 2.76%	9,375 $2.46 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $21,997 - $24,808	98 Added 1.03%	9,641 $2.17 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $118,815 - $132,221	-515 Reduced 5.12%	9,543 $2.32 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $295,137 - $326,499	1,346 Added 15.45%	10,058 $2.43 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $1.73 Million - $1.98 Million	8,712 New	8,712 $1.96 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Leeward Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Leeward Financial Partners, LLC with notifications on news.